I agree that this site is using cookies. You can find further informations here.
X
MOGUILEVSKY, N.
35  results:
Search for persons X
?
1

Myeloperoxidase and its products in synovial fluid of patie..:

Nzeusseu Toukap, A. ; Delporte, C. ; Noyon, C....
Free Radical Research.  48 (2014)  4 - p. 461-465 , 2014
Link: https://doi.org/10.3109/..
 
?
2

MS140 EFFECTS OF COPPER AND MYELOPEROXIDASE-MODIFIED LDLS O..:

Calay, D. ; Caesens-Koenig, L. ; Rousseau, A....
Atherosclerosis Supplements.  11 (2010)  2 - p. 137 , 2010
Link: https://doi.org/10.1016/..
 
?
3

MS21 COPPER AND MYELOPEROXIDASE-MODIFIED LDLS ACTIVATE NRF2..:

Calay, D. ; Rousseau, A. ; Mattart, L....
Atherosclerosis Supplements.  11 (2010)  2 - p. 113 , 2010
Link: https://doi.org/10.1016/..
 
?
4

P312 OXIDATION OF CYANIDE TO CYANATE BY MYELOPEROXIDASE: A ..:

Van Antwerpen, P. ; Zouaoui Boudjeltia, K. ; Furmueller, P....
Atherosclerosis Supplements.  11 (2010)  2 - p. 83 , 2010
Link: https://doi.org/10.1016/..
 
?
5

Neutrophil and recombinant myeloperoxidase as antigens in A..:

Short, A K ; Lockwood, C M ; Bollen, A.
Clinical and Experimental Immunology.  102 (2008)  1 - p. 106-111 , 2008
Link: https://doi.org/10.1111/..
 
?
6

TRYPTAMINE DERIVATIVES INHIBIT THE MYELOPEROXIDASE-DEPENDEN..:

Van Antwerpen, P. ; Zouaoui Boudjeltia, K. ; Dufrasne, F....
Atherosclerosis Supplements.  9 (2008)  1 - p. 56 , 2008
Link: https://doi.org/10.1016/..
 
?
7

PO10-284 INHIBITION OF THE MPO/H2O2/CHLORIDE DEPENDENT LDL ..:

Van Antwerpen, P. ; Zouaoui Boudjeltia, K. ; Dufrasne, F....
Atherosclerosis Supplements.  8 (2007)  1 - p. 87-88 , 2007
Link: https://doi.org/10.1016/..
 
?
8

Antigens and granularity of blood monocytes in relation to ..:

Zouaoui Boudjeltia, K. ; Gregoir, C. ; Guillaume, M....
Maturitas.  55 (2006)  2 - p. 132-141 , 2006
Link: https://doi.org/10.1016/..
 
?
9

The pleiotropic effect of statins in haemodialysis patients..:

Van Antwerpen, P. ; Boudjeltia, K. Zouaoui ; Vaes, M....
Nephrology Dialysis Transplantation.  21 (2006)  9 - p. 2672-2674 , 2006
Link: https://doi.org/10.1093/..
 
?
10

Th-P15:141 Flufenamic acid and its 5-hydroxy-metabolite inh..:

Van Antwerpen, P. ; Zouaoui Boudjeltia, K. ; Legssyer, I....
Atherosclerosis Supplements.  7 (2006)  3 - p. 524 , 2006
Link: https://doi.org/10.1016/..
 
?
11

W12-P-080 Comparative assessment of the inhibiting effect o..:

Van Antwerpen, P. ; Zouaoui Boudjeltia, K. ; Legssyer, I....
Atherosclerosis Supplements.  6 (2005)  1 - p. 81-82 , 2005
Link: https://doi.org/10.1016/..
 
?
12

W12-P-089 Myeloperoxidase-modified (MOX) LDL induce the pro..:

Zouaoui Boudjeltia, K. ; Legssyer, I. ; Van Antwerpen, P....
Atherosclerosis Supplements.  6 (2005)  1 - p. 84 , 2005
Link: https://doi.org/10.1016/..
 
?
13

Monoclonal antibodies against LDL progressively oxidized by..:

Moguilevsky, N. ; Zouaoui Boudjeltia, K. ; Babar, S....
Biochemical and Biophysical Research Communications.  323 (2004)  4 - p. 1223-1228 , 2004
Link: https://doi.org/10.1016/..
 
?
14

Oxidation of low density lipoproteins by myeloperoxidase at..:

Zouaoui Boudjeltia, K. ; Moguilevsky, N. ; Legssyer, I....
Biochemical and Biophysical Research Communications.  325 (2004)  2 - p. 434-438 , 2004
Link: https://doi.org/10.1016/..
 
?
15

Major role for the carboxylic function of cetirizine and le..:

Gillard, M. ; Van der Perren, C. ; Moguilevsky, N...
Inflammation Research.  51 (2002)  S1 - p. 79-80 , 2002
Link: https://doi.org/10.1007/..
 
1-15